Literature DB >> 7570733

Time dependency of the acetazolamide effect on cerebral hemodynamics in patients with chronic occlusive cerebral arteries. Early steal phenomenon demonstrated by [15O]H2O positron emission tomography.

Y Kuwabara1, Y Ichiya, M Sasaki, T Yoshida, K Masuda.   

Abstract

BACKGROUND AND
PURPOSE: The acetazolamide effect is thought to reach a maximum at 10 to 20 minutes after administration. However, we sometimes encountered patients who showed a transient deterioration of ischemic symptoms several minutes after acetazolamide administration. We therefore considered that a steal phenomenon may occur before the acetazolamide effect reaches a maximum. We evaluated the time dependency of the acetazolamide effect on cerebral hemodynamics in patients with severe stenosis or occlusion of the unilateral internal carotid artery.
METHODS: The subjects consisted of 13 patients with severe stenosis or occlusion of the unilateral internal carotid artery. Regional cerebral blood flow was measured at the resting state and at 5 and 20 minutes after the intravenous administration of 1 g acetazolamide by the use of the [15O]H2O bolus-injection method and positron emission tomography. The steal phenomenon was interpreted as positive when the regional cerebral blood flow values decreased by more than 10% after the administration of acetazolamide in more than one region of interest.
RESULTS: A steal phenomenon was observed in 5 of 13 patients at 5 minutes after acetazolamide administration on the occlusive side, whereas it was observed in only 1 patient at 20 minutes. Thus, this phenomenon was observed more frequently in the early phase of the acetazolamide test. It was also observed more frequently in patients with poorly developed collateral circulation.
CONCLUSIONS: Our acetazolamide [15O]H2O positron emission tomography study revealed an early steal phenomenon at 5 minutes after intravenous administration of acetazolamide, which may be a cause of the transient deterioration of ischemic symptoms during the acetazolamide test.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7570733     DOI: 10.1161/01.str.26.10.1825

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  10 in total

1.  Cerebral blood flow and neuropsychological functioning in elderly vascular disease patients.

Authors:  David J Moser; Laura L Boles Ponto; Ivy N Miller; Susan K Schultz; Yusuf Menda; Stephan Arndt; Peggy C Nopoulos
Journal:  J Clin Exp Neuropsychol       Date:  2011-12-13       Impact factor: 2.475

Review 2.  Vascular remodeling after ischemic stroke: mechanisms and therapeutic potentials.

Authors:  Jialing Liu; Yongting Wang; Yosuke Akamatsu; Chih Cheng Lee; R Anne Stetler; Michael T Lawton; Guo-Yuan Yang
Journal:  Prog Neurobiol       Date:  2013-11-27       Impact factor: 11.685

3.  Cerebellar vascular response to acetazolamide in crossed cerebellar diaschisis: a comparison of 99mTc-HMPAO single-photon emission tomography with 15O-H2O positron emission tomography.

Authors:  Y Kuwabara; Y Ichiya; M Sasaki; Y Akashi; T Yoshida; T Fukumura; K Masuda
Journal:  Eur J Nucl Med       Date:  1996-06

4.  Extensive brain infarction involving deep structures during an acetazolamide-challenged single-photon emission computed tomography scan in a patient with moyamoya disease.

Authors:  Sangjoon Chong; June Dong Park; Jong Hee Chae; Jung-Eun Cheon; Seung-Ki Kim; Ji Hoon Phi; Ji Yeoun Lee; Jin Chul Paeng; Kyu-Chang Wang
Journal:  Childs Nerv Syst       Date:  2017-07-08       Impact factor: 1.475

5.  Optimal timing for measuring cerebral blood flow after acetazolamide administration to detect preexisting cerebral hemodynamics and metabolism in patients with bilateral major cerebral artery steno-occlusive diseases: 15O positron emission tomography studies.

Authors:  Masakazu Kobayashi; Suguru Igarashi; Tatsuhiko Takahashi; Shunrou Fujiwara; Kohei Chida; Kazunori Terasaki; Yoshitaka Kubo; Kuniaki Ogasawara
Journal:  Am J Nucl Med Mol Imaging       Date:  2021-12-15

6.  Increased capillary stalling is associated with endothelial glycocalyx loss in subcortical vascular dementia.

Authors:  Jin-Hui Yoon; Paul Shin; Jongyoon Joo; Gaon S Kim; Wang-Yuhl Oh; Yong Jeong
Journal:  J Cereb Blood Flow Metab       Date:  2022-02-09       Impact factor: 6.960

7.  Paradoxical reduction of cerebral blood flow after acetazolamide loading: a hemodynamic and metabolic study with (15)O PET.

Authors:  Tadashi Watabe; Eku Shimosegawa; Hiroki Kato; Kayako Isohashi; Mana Ishibashi; Mitsuaki Tatsumi; Kazuo Kitagawa; Toshiyuki Fujinaka; Toshiki Yoshimine; Jun Hatazawa
Journal:  Neurosci Bull       Date:  2014-08-06       Impact factor: 5.203

8.  How temporal evolution of intracranial collaterals in acute stroke affects clinical outcomes.

Authors:  Leonard L L Yeo; Prakash Paliwal; Adrian F Low; Edgar L W Tay; Anil Gopinathan; Mahendran Nadarajah; Eric Ting; Narayanaswamy Venketasubramanian; Raymond C S Seet; Aftab Ahmad; Bernard P L Chan; Hock L Teoh; Derek Soon; Rahul Rathakrishnan; Vijay K Sharma
Journal:  Neurology       Date:  2016-01-06       Impact factor: 9.910

9.  Quantitative cerebral H2(15)O perfusion PET without arterial blood sampling, a method based on washout rate.

Authors:  Valerie Treyer; Mathieu Jobin; Cyrill Burger; Vincenzo Teneggi; Alfred Buck
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-01-28       Impact factor: 9.236

Review 10.  Basal and Acetazolamide Brain Perfusion SPECT in Internal Carotid Artery Stenosis.

Authors:  Teck Huat Wong; Qaid Ahmed Shagera; Hyun Gee Ryoo; Seunggyun Ha; Dong Soo Lee
Journal:  Nucl Med Mol Imaging       Date:  2020-01-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.